Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Cell
|
May 20, 2009
The mechanism of ATP-dependent primer-template recognition by a clamp loader complex
Kyle R Simonetta, Steven L Kazmirski, Eric R Goedken, et al.
The Journal of Investigative Dermatology
|
February 6, 2021
ACT1 Is Required for Murine IL-23-Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase Activity
Alex Lipovsky, Peter F Slivka, Zhi Su, et al.
Protein Expression and Purification
|
September 10, 2010
Functional comparison of recombinant acidic mammalian chitinase with enzyme from murine bronchoalveolar lavage
Eric R Goedken, Robert F O'Brien, Tao Xiang, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Induction of Human Pruriceptors from Pluripotent Stem Cells via Transcription Factors
Hisato Iriki, Ruiqi Hu, Xu Li, et al.
Stem Cell Reports
|
July 9, 2026
Induction of human pruriceptors from pluripotent stem cells via transcription factors
Hisato Iriki, Ruiqi Hu, Xu Li, et al.
BMC Structural Biology
|
September 22, 2012
Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor
Maria A Argiriadi, Eric R Goedken, David Banach, et al.
The Journal of Dermatology
|
July 17, 2023
Importance of PLD2 in an IL-23 driven psoriasiform dermatitis model and potential link to human psoriasis
Zhi Su, Peter Slivka, Stephanie Paulsboe, et al.
The Journal of Biological Chemistry
|
January 2, 2015
Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol
Eric R Goedken, Maria A Argiriadi, David L Banach, et al.
ACS Chemical Biology
|
April 3, 2019
Small Molecule and Pooled CRISPR Screens Investigating IL17 Signaling Identify BRD2 as a Novel Contributor to Keratinocyte Inflammatory Responses
Peter F Slivka, Chen-Lin Hsieh, Alex Lipovsky, et al.
Scientific Reports
|
August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site
Eric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Cell
|
May 20, 2009
The mechanism of ATP-dependent primer-template recognition by a clamp loader complex
Kyle R Simonetta, Steven L Kazmirski, Eric R Goedken, et al.
The Journal of Investigative Dermatology
|
February 6, 2021
ACT1 Is Required for Murine IL-23-Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase Activity
Alex Lipovsky, Peter F Slivka, Zhi Su, et al.
Protein Expression and Purification
|
September 10, 2010
Functional comparison of recombinant acidic mammalian chitinase with enzyme from murine bronchoalveolar lavage
Eric R Goedken, Robert F O'Brien, Tao Xiang, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Induction of Human Pruriceptors from Pluripotent Stem Cells via Transcription Factors
Hisato Iriki, Ruiqi Hu, Xu Li, et al.
Stem Cell Reports
|
July 9, 2026
Induction of human pruriceptors from pluripotent stem cells via transcription factors
Hisato Iriki, Ruiqi Hu, Xu Li, et al.
BMC Structural Biology
|
September 22, 2012
Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor
Maria A Argiriadi, Eric R Goedken, David Banach, et al.
The Journal of Dermatology
|
July 17, 2023
Importance of PLD2 in an IL-23 driven psoriasiform dermatitis model and potential link to human psoriasis
Zhi Su, Peter Slivka, Stephanie Paulsboe, et al.
The Journal of Biological Chemistry
|
January 2, 2015
Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol
Eric R Goedken, Maria A Argiriadi, David L Banach, et al.
ACS Chemical Biology
|
April 3, 2019
Small Molecule and Pooled CRISPR Screens Investigating IL17 Signaling Identify BRD2 as a Novel Contributor to Keratinocyte Inflammatory Responses
Peter F Slivka, Chen-Lin Hsieh, Alex Lipovsky, et al.
Scientific Reports
|
August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site
Eric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.
Page
of 3